Kalaris Therapeutics, Inc 10-K for FY2022
Kalaris Therapeutics, Inc. (KLRS)
10-K
2023-02-15
For: 2022-12-31
View Original
Added on
April 08, 2026
About this 10-K
Kalaris Therapeutics, Inc filed this 10-K on February 15, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $168.71M
- compared with a net loss of $171.96M a year earlier
- Diluted EPS
- -$2.20
- compared with -$2.74 a year earlier